Rise in drug resistant tuberculosis – onmedica.com

Drug resistant TB, when a patient fails to respond to one of the four main antibiotics used to treat the infection (isoniazid, rifampicin, ethambutol orpyrazinamide), accounted for 8.4 per cent of laboratory confirmed TB cases in 2011 (431 out of 5,127).